Celldex (CLDX) Bullish Stance Reiterated at Cantor Fitzgerald Following Q1 and Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. TSLA
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Celldex (CLDX) Bullish Stance Reiterated at Cantor Fitzgerald Following Q1 and Update

Celldex Therapeutics (CLDX) Tops Q1 EPS by 3c

April 29, 2015 8:03 AM EDT

Celldex Therapeutics (NASDAQ: CLDX) reported Q1 EPS of ($0.33), $0.03 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $406 thousand versus the consensus estimate of $460 thousand.

For earnings history and earnings-related data on (CLDX) click here.

... More